This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Resverlogix Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Robert P. Short
Introduction
Robert P. Short is an accomplished inventor based in Florence, SC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for preparing quinazolinone derivatives. His work is aimed at addressing critical health issues, including cardiovascular diseases.
Latest Patents
Robert P. Short holds a patent for "Methods of preparing quinazolinone derivatives." This patent discloses methods for preparing compounds that are useful for regulating the expression of apolipoprotein A-I (ApoA-I). These compounds play a vital role in the treatment and prevention of cardiovascular diseases and related conditions, including cholesterol- or lipid-related disorders such as atherosclerosis.
Career Highlights
Short is currently associated with Resverlogix Corporation, where he continues to innovate in the pharmaceutical sector. His expertise in the preparation of quinazolinone derivatives showcases his commitment to advancing medical science and improving patient outcomes.
Collaborations
Some of his notable coworkers include Henrik C. Hansen and Shubham P. Chopade. Their collaborative efforts contribute to the ongoing research and development initiatives at Resverlogix Corporation.
Conclusion
Robert P. Short's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions are paving the way for advancements in the treatment of cardiovascular diseases, highlighting the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile